Home > Healthcare > Biotechnology > Biopharma > Continuous Bioprocessing Market
Continuous Bioprocessing Market Size
- Report ID: GMI8350
- Published Date: Feb 2024
- Report Format: PDF
Continuous Bioprocessing Market Size
Continuous Bioprocessing Market was valued at USD 207.6 million in 2023 and is projected to grow at a CAGR of over 22.1% from 2024 to 2032. Factors such as the increasing demand for biopharmaceuticals, growing adoption of continuous bioprocessing among CMOs and CDMOs, and advancements in continuous bioprocessing technologies majorly contributes to the remarkable market growth. Also, emerging markets, particularly in Asia-Pacific, are witnessing increased adoption of continuous bioprocessing technologies to support the growing demand for biologics, thereby further boosting business development.
Continuous bioprocessing is a method used in biotechnology and biopharmaceutical manufacturing where the production process operates continuously rather than in batches. In traditional batch processing, materials are loaded into a vessel, processed for a set period, and then harvested before the vessel is cleaned and prepared for the next batch. In continuous bioprocessing, the materials flow continuously through the system, with product continuously harvested at the output.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Continuous Bioprocessing Market Size in 2023: | USD 207.6 Million |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 22.1% |
| 2032 Value Projection: | USD 1.2 billion |
| Historical Data for: | 2018 - 2023 |
| No. of Pages: | 230 |
| Tables, Charts & Figures: | 402 |
| Segments covered: | Product, Scale of Operation, Process, Application, End-user, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Continuous Bioprocessing Market Scope
